Cargando…
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073410/ https://www.ncbi.nlm.nih.gov/pubmed/32201683 http://dx.doi.org/10.1183/23120541.00328-2019 |
| _version_ | 1783506613921906688 |
|---|---|
| author | Anthi, Anastasia Stagaki, Eleni Rallidis, Loukianos Konstantonis, Dimitrios Evangelopoulos, Maria-Eleftheria Voumvourakis, Konstantinos Armaganidis, Apostolos Orfanos, Stylianos E. |
| author_facet | Anthi, Anastasia Stagaki, Eleni Rallidis, Loukianos Konstantonis, Dimitrios Evangelopoulos, Maria-Eleftheria Voumvourakis, Konstantinos Armaganidis, Apostolos Orfanos, Stylianos E. |
| author_sort | Anthi, Anastasia |
| collection | PubMed |
| description | The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP |
| format | Online Article Text |
| id | pubmed-7073410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70734102020-03-20 Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity Anthi, Anastasia Stagaki, Eleni Rallidis, Loukianos Konstantonis, Dimitrios Evangelopoulos, Maria-Eleftheria Voumvourakis, Konstantinos Armaganidis, Apostolos Orfanos, Stylianos E. ERJ Open Res Original Research Letters The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP European Respiratory Society 2020-03-16 /pmc/articles/PMC7073410/ /pubmed/32201683 http://dx.doi.org/10.1183/23120541.00328-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Original Research Letters Anthi, Anastasia Stagaki, Eleni Rallidis, Loukianos Konstantonis, Dimitrios Evangelopoulos, Maria-Eleftheria Voumvourakis, Konstantinos Armaganidis, Apostolos Orfanos, Stylianos E. Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title | Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title_full | Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title_fullStr | Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title_full_unstemmed | Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title_short | Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity |
| title_sort | is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? a case study to explore the complexity |
| topic | Original Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073410/ https://www.ncbi.nlm.nih.gov/pubmed/32201683 http://dx.doi.org/10.1183/23120541.00328-2019 |
| work_keys_str_mv | AT anthianastasia ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT stagakieleni ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT rallidisloukianos ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT konstantonisdimitrios ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT evangelopoulosmariaeleftheria ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT voumvourakiskonstantinos ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT armaganidisapostolos ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity AT orfanosstylianose ispulmonaryarterialhypertensionassociatedwithinterferonbtherapyformultiplesclerosisreversibleacasestudytoexplorethecomplexity |